Nhwa is specialized in R&D, manufacturing and trading of APIs and dosages in the field of Central Nervous System. With more than 50 years of unremitting endeavor and prominent reputation, Nhwa has become the leader of manufacturing CNS drugs in China.
Year Established: 1978
Total Number of Staff: more than 1000
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Business Type: Manufacturer
R&D Capacity: Own Brand
Annual Turnover(USD) : More than 99,999,999
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
Dexmedetomidine Hydrochloride Injection
Olanzapine
Tapentadol Hcl
Pregabalin